Xencor reported $5.46M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
AbbVie USD 72M 13M Mar/2026
Alnylam Pharmaceuticals USD 26.6M 32K Mar/2026
Arrowhead Research USD 16.87M 7.18M Mar/2026
AstraZeneca USD 80M 7M Jun/2026
Biogen USD 37.9M 700K Mar/2026
Cytokinetics USD 11.02M 448K Mar/2026
GlaxoSmithKline GBP 22M 96M Mar/2026
J&J USD 2.27 0.13 Jun/2026
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.55M 26K Mar/2026
Merck USD 35M 34M Mar/2026
Pfizer USD -0.04 115M Jun/2026
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Xencor USD 5.46M 741K Mar/2026